Myeloma and Related Diseases Registry (MRDR)

Please join us for the Annual MRDR Breakfast Meeting at Blood 2023, 7.00-8.15am AEDT. For details go to: mrdr.net.au/news/mrdr-interest-group-breakfast-meeting-at-blood-2023 Hope to see you there!

More information

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
6481

Patients accrued

4537

Patients with multiple myeloma

57

Number of approved sites

652

M1000 Biobank participants

Latest news

MRDR Interest Group Breakfast Meeting at Blood 2023!
18 Aug 2023

Please join us for our annual Interest Group breakfast at Blood 2023, 6th November.

Read more
The Austin joins M1000
07 Aug 2023

The MRDR recruits another hospital for the Myeloma 1000 Project.

Read more
MY-PROMPT-2 is kicking goals!
19 Jun 2023

MY-PROMPT-2 project randomises first patient and enrols another!

Read more
Inferior outcomes in t(11;14) multiple myeloma
14 Jun 2023

Ken Lim's paper on Inferior outcomes in t(11;14) multiple myeloma has been accepted for publication.

Read more

Participating organisations